The artificial intelligence sector continues to show robust activity, with key players like Taiwan Semiconductor (TSM) cementing its foundational role. TSM, a critical manufacturer for Nvidia, Alphabet (Google), and Advanced Micro Devices (AMD), commands 34% of the foundry market and holds a $1.5 trillion market capitalization. The company is significantly expanding its operations, investing $165 billion in Arizona, where it produced its first Nvidia Blackwell chip in October. TSM's chips power 12,000 products for 500 partners, including smartphones and self-driving cars, underscoring its broad impact. Investment sentiment reflects this AI-driven growth. Citigroup Inc. recently upgraded Taiwan's stock rating to "overweight" on December 23, 2025, citing its strong ties to the global AI industry and promising earnings forecasts, while downgrading China to "neutral." Meanwhile, the demand for AI data centers remains exceptionally strong, with aggressive bidding for megawatts reaching up to $550,000 in prime locations. Bitcoin miners are actively transitioning to high-performance computing for AI, joining large tech companies and AI firms in the competitive market for power. Individual companies are also making significant strides. BofA Securities reaffirmed its "Buy" rating for Palantir Technologies Inc. (PLTR) with a $255.00 price target after executives noted strong adoption of Palantir's AI technology. Microsoft Corp. (MSFT) saw its stock rise on December 23, 2025, closing at $486.85, as the AI market stabilized. Microsoft is prioritizing security, infrastructure, and AI-driven productivity, with plans to replace C and C++ code with Rust by 2030 using AI for enhanced security. In the realm of healthcare, Senhwa Biosciences is leveraging AI for novel cancer treatments. Google DeepMind's AI model identified Senhwa's compound Silmitasertib (CX-4945) as highly effective in boosting the immune system against cancer, particularly in "cold" tumors. Senhwa also collaborates on Pidnarulex (CX-5461) for pancreatic cancer, which helps make tumors more responsive to immunotherapies. Furthermore, Thread, an AI service desk platform for Managed Service Providers, secured $18 million in new funding, bringing its total capital to $30 million, to enhance its AI-powered Service Intelligence platform.
Key Takeaways
- Taiwan Semiconductor (TSM) is a leading AI chip manufacturer for Nvidia, Alphabet (Google), and AMD, holding 34% of the foundry market and a $1.5 trillion market cap.
- TSM is investing $165 billion in Arizona, where it produced its first Nvidia Blackwell chip in October.
- Citigroup Inc. upgraded Taiwan to "overweight" on December 23, 2025, due to its strong AI industry connection and earnings predictions.
- Demand for AI data centers is robust, with aggressive bidding for megawatts reaching up to $550,000, and bitcoin miners shifting to AI computing.
- BofA Securities maintained a "Buy" rating for Palantir Technologies (PLTR) with a $255.00 price target, noting strong AI technology adoption.
- Microsoft Corp. (MSFT) closed higher at $486.85 on December 23, 2025, focusing on AI-driven security and productivity, including plans to replace C/C++ with Rust by 2030 using AI.
- Senhwa Biosciences uses an AI-powered platform, with Google DeepMind identifying Silmitasertib (CX-4945) for boosting anti-cancer immunity.
- Senhwa Biosciences is also testing Pidnarulex (CX-5461) for pancreatic cancer, which helps turn "cold" tumors into "hot" ones.
- Thread, an AI service desk platform, raised $18 million in new funding, bringing its total capital to $30 million, to improve its AI products for MSPs.
- AI analyst Aria is positive on Micron (MU) stock, which Wall Street generally rates as a Strong Buy (28 Buy, 2 Hold).
Taiwan Semiconductor is a top AI chip stock to buy
Taiwan Semiconductor (TSM) is a leading AI stock to consider investing in. It manufactures chips for major companies like Nvidia, Alphabet, and Advanced Micro Devices, making it a core part of the AI industry. The company holds 34% of the foundry market and has expanded operations to Arizona, investing $165 billion. TSM also makes chips for smartphones and self-driving cars, powering 12,000 products for 500 partners. Its stock is up 46% this year, and it will report fourth-quarter earnings in January.
Taiwan Semiconductor a smart AI stock choice
Taiwan Semiconductor (TSM) stands out as a strong AI stock for investors. It makes chips for top companies like Nvidia, Alphabet, and Advanced Micro Devices, forming the base of AI development. TSM controls 34% of the semiconductor foundry market and has a $1.5 trillion market cap. The company is investing $165 billion in Arizona, where it produced its first Nvidia Blackwell chip in October. TSM also creates chips for smartphones and self-driving cars, serving 500 partners and 12,000 products. Its fourth-quarter earnings report in January could boost the stock further.
AI analyst Aria sees more growth for Micron stock
AI analyst Aria is very positive about Micron (MU) stock, having a 100% success rate in 2025. Aria believes Micron will continue to grow. However, some risks exist, such as limits on supply, increasing spending, and changes in board members. Despite these concerns, Wall Street analysts generally rate MU stock as a Strong Buy, with 28 Buy ratings and only two Hold ratings recently.
Citi favors Taiwan stocks over China due to AI
Citigroup Inc. has changed its investment advice, now favoring Taiwan stocks over China stocks. On December 23, 2025, Citi upgraded Taiwan to "overweight" because of its strong connection to the global AI industry and good earnings predictions. At the same time, Citi lowered China's rating to "neutral" due to weaker earnings and a slow economy. Globally, Citi still likes emerging markets, expecting them to have the best earnings growth in 2026, driven by AI investments.
BofA keeps Buy rating for Palantir after meetings
BofA Securities confirmed its "Buy" rating for Palantir Technologies Inc. (PLTR) and set a $255.00 price target. This decision came after BofA executives met with Palantir's CFO Dave Glazer and other leaders in South Korea on December 15. BofA sees strong adoption of Palantir's AI technology.
Senhwa Biosciences uses AI for new cancer treatments
Senhwa Biosciences shared updates on its AI-powered drug platform and cancer treatments at its 2025 investor conference. Google DeepMind's AI model identified Senhwa's compound Silmitasertib (CX-4945) as highly promising for boosting the immune system against cancer. This compound helps the body recognize cancer cells better, even in hard-to-treat "cold" tumors. Senhwa also works with BeOne Medicines to test Pidnarulex (CX-5461) for pancreatic cancer and advanced solid tumors. CX-5461 helps turn "cold" tumors into "hot" ones, making existing immunotherapies more effective.
AI data center demand stays strong despite market dips
Joe Nardini, an investment banker at B. Riley Securities, states that the demand for AI data centers remains very strong, even with recent stock market drops for companies like Nvidia and CoreWeave. He notes that bitcoin miners are now shifting to high-performance computing for AI, and buyers are actively seeking power. There is aggressive bidding for megawatts, with prices reaching up to $450,000 or even $550,000 per megawatt for good locations. Large tech companies, AI firms, and bitcoin miners are all looking to buy, and industrial companies with old facilities are now selling.
Microsoft stock rises as AI market stabilizes
Microsoft Corp. (MSFT) stock closed higher on December 23, 2025, with a 0.40% gain, as the AI market showed signs of stability. The company's stock ended the regular session at $486.85. Microsoft is focusing on security, infrastructure, and AI-driven productivity. A key engineer, Galen Hunt, plans to replace C and C++ code with Rust by 2030 using AI, aiming for better security. Microsoft also released an urgent fix for a Windows Message Queuing issue and is preparing new security services for 2026.
Thread raises $18 million for AI service platform
Thread, an AI service desk platform for Managed Service Providers (MSPs), raised $18 million in new funding. Susquehanna Growth Equity led the investment, bringing Thread's total capital to $30 million. The company will use this money to improve its Service Intelligence platform and AI products. Thread aims to help MSPs automate support, moving away from old ticketing systems to faster, smarter service. Its platform uses AI to understand customer interactions from chats and calls, then automates tasks like creating and solving tickets.
Sources
- 1 No-Brainer Artificial Intelligence (AI) Stock to Buy With $1,000 in December and Hold for the Long Term
- 1 No-Brainer Artificial Intelligence (AI) Stock to Buy With $1,000 in December and Hold for the Long Term
- Micron Stock (MU): AI Analyst Posts 100% Success Rate in 2025, Predicts Further Upside
- Citi Downgrades China Stocks, Lifts Taiwan on AI and Earnings
- BofA Reiterates Buy on Palantir (PLTR) After Investor Meetings, Sees Strong AI Adoption
- Senhwa Biosciences Highlights AI-Validated Oncology Platform and Strategic Clinical Collaborations Targeting Next-Generation Immuno-Oncology products at Its 2025 Annual Investor Conference
- AI data center demand ‘unabated’ despite stock selloff, industry banker says
- Microsoft Stock After Hours: MSFT Ends Dec. 23, 2025 Higher as AI Trade Stabilizes — What to Watch Before the Dec. 24 Market Open
- Thread: $18 Million Raised From Susquehanna To Expand Agentic AI Service Intelligence For MSPs
Comments
Please log in to post a comment.